LEPTOMENINGEAL DISEASE (LMD)
Clinical trials for LEPTOMENINGEAL DISEASE (LMD) explained in plain language.
Never miss a new study
Get alerted when new LEPTOMENINGEAL DISEASE (LMD) trials appear
Sign up with your email to follow new studies for LEPTOMENINGEAL DISEASE (LMD), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
First patients test new brain cancer drug in race against time
Disease control Recruiting nowThis is the first study to give the experimental drug AZD1390 to people. It aims to find a safe dose of AZD1390 to give alongside standard radiation therapy for patients with aggressive brain tumors, including glioblastoma and cancer that has spread to the brain. The main goal is…
Matched conditions: LEPTOMENINGEAL DISEASE (LMD)
Phase: PHASE1 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC
-
Spinal fluid test could revolutionize brain cancer detection
Knowledge-focused Recruiting nowThis study is exploring whether testing spinal fluid can better detect cancer that has spread to the brain or its lining compared to standard blood tests. Researchers will collect spinal fluid and blood from 60 patients with solid tumors, including those with and without brain me…
Matched conditions: LEPTOMENINGEAL DISEASE (LMD)
Phase: NA • Sponsor: Sunnybrook Health Sciences Centre • Aim: Knowledge-focused
Last updated Mar 31, 2026 12:11 UTC